» Articles » PMID: 16218460

Autoimmune Myocarditis and Dilated Cardiomyopathy: Focus on Cardiac Autoantibodies

Overview
Journal Lupus
Publisher Sage Publications
Specialty Rheumatology
Date 2005 Oct 13
PMID 16218460
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Criteria of organ-specific autoimmunity are fulfilled in a subset of patients with myocarditis/dilated cardiomyopathy (DCM). In particular, circulating heart-reactive autoantibodies are found in patients and symptom-free relatives. These autoantibodies are directed against multiple antigens, some of which are expressed in the heart (organ-specific), others in heart and some skeletal muscle fibres (partially-heart specific) or in heart and skeletal muscle (muscle-specific). Distinct autoantibodies have different frequency in disease and normal controls. Different techniques detect one or more antibodies, thus they cannot be used interchangeably for screening. It is unknown whether the same patients produce more antibodies or different patient groups develop autoimmunity to distinct antigens. IgG antibodies, shown to be cardiac and disease-specific for myocarditis/DCM, can be used as autoimmune markers for identifying patients in whom immunosuppression may be beneficial and relatives at risk. Some autoantibodies may also have a functional role, but further work is needed.

Citing Articles

Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure.

Zweck E, Karschnia M, Scheiber D, Heidecke H, Dechend R, Barthuber C ESC Heart Fail. 2023; 10(2):1258-1269.

PMID: 36717981 PMC: 10053254. DOI: 10.1002/ehf2.14293.


Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection.

Basavalingappa R, Arumugam R, Lasrado N, Yalaka B, Massilamany C, Gangaplara A Mol Immunol. 2020; 124:218-228.

PMID: 32615275 PMC: 7363587. DOI: 10.1016/j.molimm.2020.06.017.


Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.

van den Hoogen P, de Jager S, Mol E, Schoneveld A, Huibers M, Vink A PLoS One. 2020; 14(12):e0227283.

PMID: 31891633 PMC: 6938331. DOI: 10.1371/journal.pone.0227283.


Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.

Lynch 4th T, Ismahil M, Jegga A, Zilliox M, Troidl C, Prabhu S J Mol Cell Cardiol. 2016; 102:83-93.

PMID: 27955979 PMC: 5316303. DOI: 10.1016/j.yjmcc.2016.12.002.


Identification of α-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR).

Chin M, Hooper L, Hooks J, Detrick B J Neuroimmunol. 2014; 272(1-2):42-50.

PMID: 24864013 PMC: 7112846. DOI: 10.1016/j.jneuroim.2014.05.002.